Table 3.
Outcome data by tumor entity
| Primary tumor site | AWD n = 27 (%) |
DOD n = 95 (%) |
DOC n = 3 (%) |
DOO n = 11 (%) |
Not specified n = 9 (%) |
|---|---|---|---|---|---|
| Breast carcinoma (n = 31) | 6 (22.2) | 19 (20.0) | 1 (33.3) | 3 (27.3) | 2 (22.2) |
| Renal cell carcinoma (n = 15) | 3 (11.1) | 11 (11.6) | 1 (9.1) | ||
| Urothelial Carcinoma (n = 3) | 2 (2.1) | 1 (11.1) | |||
| Prostate carcinoma (n = 27) | 8 (29.6) | 12 (12.6) | 5 (45.5) | 2 (22.2) | |
| Bronchial Carcinoma (n = 27) | 4 (14.8) | 22 (23.2) | 1 (11.1) | ||
| CUP adenocarcinoma (n = 6) | 1 (3.7) | 2 (2.1) | 3 (33.3) | ||
| Esophageal carcinoma (n = 3) | 3 (3.2) | ||||
| Colon carcinoma (n = 1) | 1 (9.1) | ||||
| Rectal carcinoma (n = 3) | 3 (3.2) | ||||
| Thyroid carcinoma (n = 1) | 1 (1.1) | ||||
| Laryngeal carcinoma (n = 1) | 1 (1.1) | ||||
| Rhabdomyosarcoma (n = 2) | 2 (2.1) | ||||
| Leiomyosarcoma (n = 1) | 1 (1.1) | ||||
| Angiosarcoma (n = 2) | 2 (2.1) | ||||
| Multiple myeloma (n = 15) | 2 (7.4) | 10 (10.5) | 2 (66.7) | 1 (9.1) | |
| B-cell lymphoma (n = 2) | 1 (3.7) | 1 (1.1) | |||
| Chronic lymphocytic leukemia (n = 1) | 1 (3.7) | ||||
| Malignant melanoma (n = 1) | 1 (3.7) | ||||
| Penile carcinoma (n = 1) | 1 (1.1) | ||||
| Hepatocellular carcinoma (n = 1) | 1 (2.1) | ||||
| Gastrointestinal stromal tumor (n = 1) | 1 (1.1) |
Abbreviations AWD = alive with disease, DOD = died of disease, DOC = died of complications, DOO = died of other circumstances